Alexandria Real Estate Equities, Inc.

As of July 21, 2025, Alexandria Real Estate Equities, Inc. is considered risky and overvalued, with a P/E ratio of 32 compared to a peer average of 44.49, a low ROCE of 3.35%, and a stock decline of 29.40% over the past year, indicating significant performance issues.

As of April 14, 2025, Alexandria Real Estate Equities, Inc. is considered very attractive due to its undervalued status with a P/E ratio of 32, a price-to-book value of 0.70, a competitive EV to EBITDA ratio of 6.41, and a high dividend yield of 743.12%, despite a 37.44% decline over the past year compared to the S&P 500's 10.26% gain.

As of June 18, 2025, the trend is mildly bearish, influenced by daily moving averages and Bollinger Bands, despite some bullish signals from the weekly MACD and RSI.

As of March 2022, the management team of Alexandria Real Estate Equities, Inc. includes Executive Chairman Joel Marcus, Lead Independent Director Steven Hash, and Independent Directors James Richardson, John Atkins, Amb. James Cain, and Dr. Maria Freire, who oversee the company's strategic direction and governance.

Alexandria Real Estate Equities, Inc. is a REIT that leases space to the life science and technology sectors, focusing on collaborative campuses. As of March 2025, it reported net sales of $758 million and a market cap of approximately $12.32 billion.

As of Jun 18, Alexandria Real Estate Equities, Inc. has a market capitalization of $12.32 billion, with net sales of $3.11 billion and a net profit of $317.82 million for the latest four quarters. The balance sheet shows shareholder's funds of $17.89 billion and total assets of $37.53 billion.